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Abstract 
Autism spectrum disorders (ASD) are complex genetic disorders more frequently observed in males. 
Skewed X chromosome inactivation (XCI) is observed in heterozygous females carrying gene 
mutations involved in several X-linked syndromes. In this study, we aimed to estimate the role of X-
linked genes in the susceptibility to ASD by ascertaining the XCI pattern in a sample of 543 
informative mothers of children with ASD and in a sample of 163 affected girls. The XCI pattern was 
also determined in two control groups (144 adult females and 40 young females) with a similar age 
distribution to the mothers sample and affected girls sample, respectively. We observed no significant 
excess of skewed XCI in families with ASD. Interestingly, two mothers and one girl carrying known 
mutations in X-linked genes (NLGN3, ATRX, MECP2) showed highly skewed XCI, suggesting that 
ascertainment of XCI could reveal families with X-linked mutations. Linkage analysis was carried out 
in the subgroup of multiplex families with skewed XCI (80:20) and a modest increased allele sharing 
was obtained in the Xq27-Xq28 region, with a peak Z-score of 1.75 close to rs719489. In summary, 
our results suggest that there is no major X-linked gene subject to XCI and expressed in blood cells 
conferring susceptibility to ASD. However, the possibility that rare mutations in X-linked genes could 
contribute to ASD cannot be excluded. We propose that the XCI profile could be a useful criteria to 
prioritize families for mutation screening of X-linked candidate genes.  
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Introduction 
Autism spectrum disorders (ASD) are characterized by impairments in communication, social 
interaction, and repetitive and stereotyped patterns of behaviors and interests. Although the genes for 
ASD remain largely unknown, twin and family studies indicate a large genetic contribution to ASD 
[Freitag, 2007]. ASD is more frequent in males than females, with an approximate ratio of 4:1. 
Despite this male susceptibility, whole genome scans conducted in families with at least two affected 
members did not detect major X-linked loci [Freitag, 2007; Autism Genome Project Consortium et al., 
2007]. The Y chromosome was also studied using informative single nucleotide polymorphisms 
(SNP), but no haplotype was found associated with ASD [Jamain et al., 2002]. Although these results 
suggest a limited role of the sex chromosomes in the susceptibility to ASD, they do not exclude the 
role of some X or Y-linked genes in a subset of affected individuals. Indeed, mutations in two X-
linked genes encoding neuroligins NLGN3 and NLGN4X were identified in males with ASD [Jamain 
et al., 2003]. In addition, mutations in the X-linked genes for fragile X-related protein 1 (FMR1) and 
methyl-CpG-binding protein 2 (MECP2) are associated with ASD in some cases [Carney et al., 2003; 
Reddy, 2005]. 
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To ensure equal expression of X-linked genes in both sexes, one X chromosome is inactivated at 
random in every cell in females. X chromosome inactivation (XCI) occurs early in the development of 
embryos and the process has been divided into three phases: initiation, spreading, and maintenance 
[Heard et al., 1997]. Non-random XCI or skewing is a rare event in the normal female population 
[Amos-Landgraf et al., 2006]. In contrast, an extremely skewed XCI can be observed in heterozygous 
females carrying gene mutations involved in X-linked syndromes such as X-linked mental retardation, 
Barth syndrome and X-linked sideroblastic anemia [Orstavik et al., 1998; Cazzola et al., 2000; Plenge 
et al., 2002]. In ASD, no study had been performed to ascertain the XCI pattern in mothers of affected 
children, but Talebizadeh et al. [2005] reported an excess of XCI skewing in affected girls (33%, 
10/30) compared to controls (11%, 4/35). The reason for this non-random X inactivation remains 
unclear and could be the consequence of a selection against or for cells carrying mutations on the 
active X chromosome [Muers et al., 2007]. In this study, we aimed to estimate the role of X-linked 
genes in the susceptibility to ASD by ascertaining the XCI patterns in a large sample of mothers of 
patients with ASD and affected female patients. 
 
Materials and Methods 
Subjects 
The study sample included a total of 621 mothers of children with ASD and 182 affected girls from 
three research groups: the Paris Autism Research International Sib-pair (PARIS) study, the Finnish 
study group for ASD and the International Molecular Genetic Study of Autism Consortium 
(IMGSAC; Table 1). The two control groups used for this study were obtained from anonymous blood 
donors, and consisted in 162 adult female subjects and 47 young female subjects (Table I). Four ASD 
families carrying previously identified X-linked mutations were included for comparison purposes: 
three sib pair families carrying maternally-inherited mutations in the NLGN3, NLGN4X [Jamain et al., 
2003] and ATRX genes, respectively, as well as a singleton family with a de novo R294X mutation of 
MECP2 in a girl with autism and no classical features of Rett syndrome.  
The assessment methods and inclusion criteria for the three family collections have been 
previously described [Philippe et al., 1999; IMGSAC, 2001; Auranen et al., 2002]. Briefly, all patients 
met ICD-10 and/or DSM-IV diagnostic criteria for autism or pervasive developmental disorder not 
otherwise specified (PDD-NOS). Diagnosis was based on the Autism Diagnostic Interview-Revised 
(ADI-R) [Lord et al., 1994], the Autism Diagnostic Observation Schedule (ADOS) [Lord et al., 1989] 
and clinical evaluation. Cases were excluded if they had known medical disorders or chromosomal 
abnormalities. Informed, written consent was obtained from all participating subjects or their parents. 
X Inactivation Analysis 
The X inactivation assay was carried out on genomic DNA extracted from peripheral blood or 
lymphoblast cell lines. XCI was calculated as the ratio of the peak heights of two alleles of the highly 
polymorphic CAG repeat of the androgen receptor (AR) after digestion with the methylation sensitive 
enzyme HpaII, corrected with the ratio of the peak heights of the two alleles before digestion for 
H
AL author m
anuscript    inserm
-00276460, version 1
Gong et al. 4 
preferential amplification of one of the alleles [Amos-Landgraf et al., 2006]. Briefly, 100 ng of 
genomic DNA was digested with 5 U RsaI plus 15 U HpaII, and with 5 U RsaI alone at 37°C 
overnight. Then the mixture was PCR amplified with forward primer 5'-TCC AGA ATC TGT TCC 
AGA GCG TGC-3', fluorescently labeled with 6-FAM (6-carboxyfluorescein) and reverse primer 5'-
GCT GTG AAG GTT GCT GTT CCT CAT-3'. The resulting PCR products were run on ABI 3700 or 
ABI 3730 DNA sequencer and the peak height was measured by Genescan software (Applied 
Biosystems, Foster City, CA). 
The range of XCI ratio is from 50:50 (random XCI) to 100:0 (complete non-random XCI). One 
female sample with known XCI ratio (80:20 or 95:5) and one male sample were used as controls in 
each batch of samples to verify the complete digestion and replication. For all IMGSAC samples the X 
inactivation assay was run in duplicate, showing very high reproducibility (mean standard deviation 
between replicas = 1.21). Skewed XCI was assigned by two thresholds: 80:20 and 90:10. The 
frequency of XCI skewing was analyzed with Fisher's exact test using SPSS 12.0. 
Linkage study  
For the linkage analysis of the X chromosome we utilized the genotyping data generated by the 
Autism Genome Project (AGP) using Affymetrix 10K v2 SNP array [Autism Genome Project 
Consortium et al., 2007]. SNP data were available for 185 multiplex families from IMGSAC and 
PARIS, which passed quality check and were informative for XCI analysis. Linkage analysis was also 
carried out in the subgroup of 28 multiplex families with XCI skewing (80:20). No complete SNP data 
was available for four IMGSAC and six PARIS families with skewed XCI. Non-parametric linkage 
(NPL) analysis was performed using the NPL “all” statistic implemented in the Merlin program 
[Abecasis et al., 2002], that uses the Kong and Cox linear model to evaluate the evidence for linkage. 
This model is designed to identify small increases in allele sharing spread across a large number of 
families. To model linkage disequilibrium in Merlin, we used an option that allows to calculate 
pairwise r2 between neighboring markers and create a cluster joining markers for which pairwise r2 > 
0.2. Empirical significance was estimated by simulating 1,000 replicates of the X chromosome 
genotypes conditional on the original family structure, marker spacing, allele frequencies and missing 
data.  
MECP2 and FMR1 screening 
Mutation screening of MECP2 and FMR1 was performed by sequencing all the coding regions and 
splice junctions. Primers and conditions used for MECP2 have been previously described [Beyer et al., 
2002]. FMR1 primers and PCR conditions are available on request. Real-time quantitative PCR 
analysis of the MECP2 gene was carried out using the comparative ddCt method with SYBR-green as 
previously described [Van Esch et al., 2005]. Two primer sets of the MECP2 gene [Van Esch et al., 
2005] were validated to have the same efficiency of amplification to that of the primer pair for the 
NXF5 gene on Xq22, used as reference sequence for normalization. For relative quantification the 
reaction mix consisted of Power SYBRGreen PCR Master Mix (Applied Biosystems), with 500 nM of 
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each primer and 10 ng of DNA in a final volume of 15 µl. Reactions were done in triplicate and run on 
7500 Fast Real-Time PCR System (Applied Biosystems). One normal male sample and one male 
sample carrying a large duplication including the MECP2 gene were used as controls in each run.  
 
Results 
Three independent samples of autism families and two control samples were analyzed (Table II). ASD 
families were subdivided according to the sex of affected children: families with affected males only 
(MO) and families containing one or more affected females (female containing, FC), since MO 
families are more likely to carry X-linked recessive mutations.  
The rate of skewed XCI in unaffected females is known to increase with age [Busque et al., 
1996]. For this reason, a group of 144 adult females with an age distribution similar to the sample of 
mothers was used as control population. Similarly, a group of 40 young females was used as control 
for the sample of affected girls. The pattern of XCI in the adult female control sample (80:20: 12.5%; 
90:10: 3.5%) was similar to previously published studies [Amos-Landgraf et al., 2006]. 
We did not identify a different distribution of XCI patterns between mothers of affected children 
and the adult controls (P = 1.00, Chi-square test; Fig. 1). Data for the XCI skewing threshold of 80:20 
and 90:10 are shown in Table II. No significant differences were present for the subgroups of MO 
mothers and FC mothers in each independent sample (PARIS, Finland, and IMGSAC) as well as in 
the combined sample. We also observed no statistical difference between affected females and the 
sample of young female controls. 
Interestingly, three out of the four families carrying known X-linked mutations had skewed XCI. 
In the first family, the mother had extremely skewed XCI (92:8) and transmitted a R451C mutation of 
NLGN3 to her two affected sons [Jamain et al., 2003]. In the second family, the mother showed XCI 
skewing (95:5) and transmitted an ATRX mutation G1676A to her two affected sons. NLGN3 (56 cM) 
and ATRX (57 cM) are tightly linked to AR (53 cM) and therefore recombination is an unlikely event 
among them. n both cases, the mutations were associated with the inactivated allele of AR. In the 
singleton family, the affected girl had highly skewed XCI (92:8) and a de novo R294X mutation of 
MECP2. As expected, in the family with a frameshift mutation in the NLGN4X gene, the carrier 
mother had random XCI, since NLGN4X escapes XCI [Carrel and Willard, 2005].  
A total of 86 mothers of affected children without known mutations showed highly skewed XCI 
(80:20), 45 of which are from multiplex families. These can be classified in three groups: 26 families 
with two affected boys (brothers or cousins), thus consistent with segregation of a X-linked recessive 
mutation; 14 families with male-female probands or two female probands; the female probands from 
these families showed random inactivation except for two girls with skewed XCI ≥ 80:20. Finally, five 
extended pedigrees contained affected cousin pairs related through their fathers, and are thus 
incompatible with X-linked segregation. There were 41 mothers of singletons, of which 33 had one 
affected son and 8 had one affected daughter with random XCI. 
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Using X-linked markers, we investigated if the subgroup of multiplex families with highly 
skewed XCI showed evidence of linkage, which could point to a region containing possible X-linked 
causative gene(s). NPL analysis was performed on multiplex families from the IMGSAC and PARIS 
collections. Genotypes were available for 185 multiplex families informative for XCI. 
No significant linkage was present in the whole sample. When the subgroup of 28 multiplex 
families with skewed XCI (≥80:20) and consistent with X-linked segregation (18 MO families and 10 
FC families) was analyzed, only a modest increased allele sharing was detected in the Xq27-Xq28 
region, with a peak Z-score of 1.75 close to rs719489 (Fig. 2). The empirical P-value of this result, 
calculated through simulation, was not significant (P = 0.39). A very similar NPL linkage profile was 
obtained for the smaller subgroup of 18 MO families with skewed XCI (≥80:20) (data not shown). 
Although the sample size of the skewed XCI group is too small to provide conclusive results, the lack 
of significant linkage suggests that no major X-linked locus is likely to be involved in these ASD 
families with skewed XCI. We note, however, that within the Xq27-q28 region, two genes (FMR1 and 
MECP2) are associated with ASD in some cases and therefore represent candidates for the disorder. 
FMR1 is responsible for the fragile X syndrome. The presence of (CCG)n trinucleotide repeat 
expansions has been previously excluded in at least one affected male from each family of our sample 
[Philippe et al., 1999; IMGSAC, 2001; Auranen et al., 2002]. Moreover, mutation screening of the 
coding region of FMR1 in 22 IMGSAC multiplex families with skewed XCI and allele sharing at 
Xq27-28 failed to identify any causative mutation. The MECP2 gene is responsible for up to 80% of 
the cases of Rett syndrome in females and for a proportion of syndromic and non-syndromic forms of 
mental retardation (MR) in males. Recently, Xq28 duplications including MECP2 have been identified 
in families with MR, with asymptomatic carrier females showing extreme (>85%) skewing of XCI 
[Beyer et al., 2002; Del Gaudio et al., 2006]. For these reasons, we performed a mutation screen and 
quantitative real time PCR analysis (qPCR) of MECP2 in 22 unrelated probands from all IMGSAC 
multiplex families showing XCI skewing and compatible with linkage at Xq27-28, and in 11 probands 
from IMGSAC singletons families with skewed XCI. We did not find any point mutations, deletions 
or duplications in MECP2. 
 
Discussion  
Our study showed no significant excess of XCI skewing in a large sample of mothers of children with 
ASD and no evidence for a large excess of XCI skewing in females with ASD, in contrast to the 
findings obtained in a previous study [Talebizadeh et al., 2005]. Using XCI approach, our results are 
consistent with previously published linkage studies [Freitag, 2007], suggesting that there is no major 
X-linked gene subject to XCI conferring susceptibility to ASD. However, the possibility that X-linked 
genes escaping XCI could contribute to the excess of males with ASD cannot be excluded. Indeed, not 
all X-linked genes are subject to XCI and not all X-linked mutations lead to XCI skewing. In addition, 
no conclusions can be drawn for genes that are not expressed in blood or blood stem cells. Despite 
these limitations, our results demonstrate that the XCI profile is useful for detecting families carrying 
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X-linked mutations since families with known mutations in NLGN3, ATRX, and MECP2 were 
detected by this approach. Therefore, we propose that the XCI profile could be used to reduce 
heterogeneity by selecting families more likely to carry X-linked mutations and to improve the 
identification of new genes associated with ASD. According to this hypothesis, we stratified the 
linkage analysis by selecting families with high XCI skewing. Using the subgroup with XCI skewing 
(80:20), we observed a modest increase of allele sharing in the region Xq27-Xq28, which did not 
reach empirical significance. The non-significant result can be due to the small sample size of families 
showing XCI skewing; therefore we cannot exclude that one or more genes in this region could play a 
role in the susceptibility to ASD in a minority of cases. Previous studies have also provided modest 
support for an autism susceptibility locus at the same X chromosomal region. Vincent et al. [2005] 
achieved a maximum MLOD of 1.7 at the Xq27-q28 locus in 22 multiplex autism families. In 
addition, Gauthier et al. [2006] reported an association with ASD at DXS8043 located on Xq27.3 (P = 
0.01 for allele analysis and P = 0.00001 for haplotype analysis) in French-Canadian males. Within this 
broad region, FMR1 and MECP2 are strong candidate genes, but mutation screening of MECP2 and 
FMR1 failed to identify any causative mutations in IMGSAC families with skewed XCI. Among the 
other interesting candidate genes within this region is the ribosomal protein gene RPL10, which has 
been previously shown to harbor missense mutations in two independent autism families [Klauck et 
al., 2006]. 
In summary, our results suggest that there is no major X-linked gene subject to XCI and 
expressed in blood cells conferring susceptibility to ASD. However, the XCI profile could be a useful 
criteria to prioritize families for mutation screening of X-linked candidate genes in ASD. 
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Table I. Subjects Included in the Study 
Samples N Mean age±SD 
PARIS 
 Mothers (multiplex fam)   72 43±8.9 
 Mothers (singleton fam) 217 41±8.0 
 Mothers (all fam) 289 42±8.4 
 Affected girls   85 12±8.3 
Finland 
 Mothers (multiplex fam)   13 41±7.7 
 Mothers (singleton fam)   44 43±6.7 
 Mothers (all fam)   57 43±6.9 
 Affected girls   22 15±6.2 
IMGSAC 
 Mothers (multiplex fam) 201 39±6.6 
 Mothers (singleton fam)   74 40±4.9 
 Mothers (all fam) 275 39±6.2 
 Affected girls   75   9±5.6 
All samples 
 Mothers (multiplex fam) 286 40±7.1 
 Mothers (singleton fam) 335 41±7.5 
 Mothers (all fam) 621 41±7.4 
 Affected girls 182 11±7.6 
Controls 
 Adult females 162 39±8.0 
 Young girls   47   8±4.8 
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Table II. Skewed X-inactivation in ASD Families and Controls 
Samples N Informativea XCI≥80:20 P-valueb XCI≥90:10  P-valueb 
PARIS 
Mothers of MO 200 168 29(17.3%) 0.155 7 (4.2%) 0.494 
Mothers of FC 89 78 9(11.5%) 0.509 3 (3.8%) 0.578 
Affected girls 85 75 7(9.3%) 0.164 1 (1.3%) 0.652 
Finland 
Mothers of MO 37 31 5 (16.1%) 0.385 2 (6.5%) 0.36 
Mothers of FC 20 17 4 (23.5%) 0.184 2 (11.2%) 0.161 
Affected girls 22 19 3 (15.8%) 0.593 1 (5.3%) 0.322 
IMGSAC 
Mother of MO 197 181 28 (15.5%) 0.274 9 (5.0%) 0.353 
Mother of FC 78 68 11 (16.2%) 0.299 3 (4.4%) 0.502 
Affected girls 75 69 5 (7.2%) 0.093 1 (1.4%) 0.633 
All samples 
Mother of MO 434 380 62 (16.3%) 0.172 18 (4.7%) 0.359 
Mother of FC 187 163 24 (14.7%) 0.346 8 (4.9%) 0.37 
All mothers 621 543 86 (15.8%) 0.195 26 (4.8%) 0.339 
Affected girls 182 163 15 (9.2%) 0.112 3 (1.8%) 0.516 
Controls 
Adult controls 162 144 18 (12.5%)  5 (3.5%)  
     Girls controls 47 40 7 (17.5%)  0 
a Number of families without known mutations informative for XCI analysis. 
b P-value for one-sided Fisher's exact test. 
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Figure 1. Distribution of X-inactivation ratios in 543 informative mothers and 144 adult controls. 
 
 
 
 
 
 
 
Figure 2. Non-parametric linkage analysis in the 185 multiplex families and in the subgroup of 28 
families with skewed XCI  80:20. The peak for the skewed subgroup is Z = 1.75 (LOD = 0.85) at 
Xq27-Xq28, close to rs719489. 
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